📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease. (2020)

First Author: Sazonovs A

Attributed to: The UK Inflammatory Bowel Disease Bioresource: Progressing from Genetics to Function and Clinical Translation in Crohn's Disease & Ulcerative Colitis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1053/j.gastro.2019.09.041

PubMed Identifier: 31600487

Publication URI: http://europepmc.org/abstract/MED/31600487

Type: Journal Article/Review

Volume: 158

Parent Publication: Gastroenterology

Issue: 1

ISSN: 0016-5085